Caplin Point Laboratories Limited

BSE:524742 Stock Report

Market Cap: ₹197.4b

Caplin Point Laboratories Management

Management criteria checks 4/4

Caplin Point Laboratories' CEO is Sridhar Ganesan, appointed in Mar 2015, has a tenure of 9.75 years. total yearly compensation is ₹9.30M, comprised of 95.7% salary and 4.3% bonuses, including company stock and options. directly owns 0.13% of the company’s shares, worth ₹256.39M. The average tenure of the management team and the board of directors is 8.8 years and 3.5 years respectively.

Key information

Sridhar Ganesan

Chief executive officer

₹9.3m

Total compensation

CEO salary percentage95.7%
CEO tenure9.8yrs
CEO ownership0.1%
Management average tenure8.8yrs
Board average tenure3.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sridhar Ganesan's remuneration changed compared to Caplin Point Laboratories's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹5b

Jun 30 2024n/an/a

₹5b

Mar 31 2024₹9m₹9m

₹5b

Dec 31 2023n/an/a

₹4b

Sep 30 2023n/an/a

₹4b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹9m₹8m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹3b

Jun 30 2022n/an/a

₹3b

Mar 31 2022₹6m₹5m

₹3b

Dec 31 2021n/an/a

₹3b

Sep 30 2021n/an/a

₹3b

Jun 30 2021n/an/a

₹3b

Mar 31 2021₹6m₹5m

₹2b

Dec 31 2020n/an/a

₹2b

Sep 30 2020n/an/a

₹2b

Jun 30 2020n/an/a

₹2b

Mar 31 2020₹6m₹6m

₹2b

Dec 31 2019n/an/a

₹2b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹2b

Mar 31 2019₹6m₹6m

₹2b

Dec 31 2018n/an/a

₹2b

Sep 30 2018n/an/a

₹2b

Jun 30 2018n/an/a

₹1b

Mar 31 2018₹6m₹6m

₹1b

Compensation vs Market: Sridhar's total compensation ($USD108.89K) is below average for companies of similar size in the Indian market ($USD475.64K).

Compensation vs Earnings: Sridhar's compensation has been consistent with company performance over the past year.

CEO

Sridhar Ganesan (69 yo)

9.8yrs

Tenure

₹9,300,000

Compensation

Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...

Leadership Team

NamePositionTenureCompensationOwnership
Sridhar Ganesan
MD & Whole Time Director9.8yrs₹9.30m0.13%
₹ 256.4m
D. Muralidharan
Chief Financial Officer8.8yrs₹9.10m0.020%
₹ 39.4m
Partheeban Siddarth
Chief Operating Officer13.3yrs₹1.90m11.84%
₹ 23.4b
G. Venkatram
General Counsel2.3yrs₹6.50mno data
M. Narayanan
Deputy Chief Financial Officerno datano datano data
Ashok Partheeban
Head of Marketing - Latam Businessno datano data11.91%
₹ 23.5b
Thiagaraja Manikandan
Chief Transformation & Digital Officerless than a yearno datano data

8.8yrs

Average Tenure

Experienced Management: 524742's management team is seasoned and experienced (8.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sridhar Ganesan
MD & Whole Time Director10.8yrs₹9.30m0.13%
₹ 256.4m
Paarthipan Chellappan
Non-Executive Non-Independent Chairman34.7yrsno data18.64%
₹ 36.8b
Chanderkanta Gariyali
Non-Executive Independent Director4.8yrs₹140.00kno data
R. Nagendran
Non-Executive Independent Director2.3yrs₹160.00kno data
S. Deenadayalan
Independent Non-Executive Director2.3yrs₹180.00k0.000090%
₹ 177.6k
R. Vijayaraghavan
Independent Directorless than a yearno datano data

3.5yrs

Average Tenure

72yo

Average Age

Experienced Board: 524742's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 23:01
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Caplin Point Laboratories Limited is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Kameswari V. S. ChavaliFirstCall Research
Siddhant KhandekarICICIdirect.com